Opinion: Businesses across the supply chain must work together to make Covid-19 vaccines

STAT January 14, 2021
Andrey Zarur

As a scientist leading a company focused on RNA, I have cheered Pfizer, BioNTech, Moderna, and others as the biopharmaceutical industry raced to create vaccines that will end the tragic loss of life and the economic devastation wrought by Covid-19.

So far, two Covid-19 vaccines, one from Pfizer/BioNTech and one from Moderna, have been approved by the FDA under emergency use authorizations. Both are RNA-based vaccines that show strong efficacy and few side effects. Other vaccines, using other technologies, have been approved for use in other countries.

While RNA science has been developing for two decades, this is the first time we have needed to make billions of doses ASAP. Ingredients for these mRNA vaccines that were stockpiled in advance...

Today's Sponsors

Today's Sponsor